Location History:
- San Antonio, TX (US) (1990)
- Boerne, TX (US) (2003)
Company Filing History:
1 out of 2,202 
1 out of 1,193 Years Active: 1990-2003
Title: Kevin B Temeyer: Innovator in Veterinary Vaccines and Monoclonal Antibodies
Introduction
Kevin B Temeyer is a notable inventor based in Boerne, Texas, who has made significant contributions to the field of veterinary medicine. He holds 2 patents that focus on innovative solutions for animal health, particularly in the protection of cattle from various diseases.
Latest Patents
One of Temeyer's latest patents involves the development of vaccines aimed at protecting cattle from psoroptic scabies. This patent discloses a novel antigenic protein that effectively stimulates antibody production in animals against the sheep scab mite. The administration of this protein in cattle provides protection from infestation by eliciting an immediate-type hypersensitivity response and/or immunizing the animal. Additionally, the protein is effective for producing and/or binding antibodies and may be utilized as an immunodiagnostic reagent. Another significant patent pertains to the creation of murine hybridomas that produce monoclonal antibodies specific to the crystal protein of Bacillus thuringiensis. This invention includes a modified ELISA method that enhances sensitivity for detecting antibodies specific to the crystal protein, leading to the identification of hybridomas that secrete monoclonal IgG3 antibodies.
Career Highlights
Throughout his career, Temeyer has worked with esteemed organizations, including the United States of America as represented by the Secretary of Agriculture. His work has focused on advancing veterinary science and improving animal health through innovative research and development.
Collaborations
Temeyer has collaborated with notable colleagues such as John H Pruett and Maurice Haufler, contributing to the advancement of his research and inventions.
Conclusion
Kevin B Temeyer is a distinguished inventor whose work in veterinary vaccines and monoclonal antibodies has made a significant impact on animal health. His innovative patents reflect his commitment to improving the well-being of livestock through scientific advancements.